Projects per year
Personal profile
Biography
Julie Stout is a Professor in the School of Psychological Sciences at Monash University. She leads a team of post-docs, students, and IT specialists, employing techniques from neuropsychology and cognitive neuroscience to characterise the effects of neurodegeneration on cognition and brain function. Her research group is known for innovations in assessments using computerised and sensor-based approaches.
Professor Stout is a leading international expert in Huntington’s Disease. Her team has led the cognitive component of several large, international studies, which have described the cognitive, motor, psychiatric, and brain imaging changes in people with the Huntington’s Disease gene as they progress from normal functioning to manifest Huntington’s Disease. Professor Stout also led a 20-site international study that yielded the HD-CAB, which is now the standard cognitive assessment battery for clinical trials in Huntington’s Disease. Professor Stout also co-leads the Scientific Planning Committee of Enroll-HD, the largest ever study of people from Huntington’s Disease families, which has over 12,000 participants globally. A key translation of Professor Stout’s research is that the diagnosis of Huntington’s Disease is now being refined to take into account, for the first time, cognitive changes rather than focusing exclusively on the movement disorder symptoms.
In Australia, Julie leads the Huntington’s Disease Network of Australia (HDNA), with funding from the NHMRC via an Investigator Grant. The HDNA, through a team of researchers at Monash University and in collaboration with nationally representative stakeholders, has developed and implemented the Map-HD Registry, which is Australia’s first ever registry for people with HD and their carers. The HDNA is also conducting a prevalence study of HD in Australia and is looking at a model of care for the Australian context. The HDNA is also developing a clinical trials network, and addressing preparations needed to be able to rapidly deploy new treatments in Australia once they are identified in global clinical trials.
Professor Stout is Director of Zindametrix Pty Ltd., which is a company that provides an assessment platform and services for cognitive assessment in clinical trials to pharmaceutical sponsors. Her team collaborates with multiple industry partners, pushing innovation by integrating emerging technologies such as mobile devices and sensors into clinical trials, with the aim of capturing individual differences in both disease phenotypes and responsivity to treatments.
Clinical activities
Clinical Research Psychologist, Department of Veterans' Affairs Medical Center, San Diego, California, 1992-1995
Post-doctoral Fellow, Brain Image Analysis Laboratory, Department of Psychiatry, University of California, San Diego, California, 1992-1994
Assistant Project Scientist, Brain Image Analysis Laboratory, Department of Psychiatry, University of California, San Diego, California, 1994-1995
Director, Clinical and Cognitive Neuroscience Laboratory, Indiana University, 1995-2009
Assistant Professor, Department of Psychology, Programs in Neural Science and Cognitive Science, Indiana University, Bloomington, Indiana, 1995-2003
Adjunct Assistant Professor of Clinical Psychology, Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana, 1995-2003
Associate Professor, Department of Psychology, Programs in Neural Science, Clinical Science and Cognitive Science, Indiana University, Bloomington, Indiana, 2003-2007
Adjunct Associate Professor of Clinical Psychology, Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana, 2003-2007
Director, Imaging Research Facility, Indiana University, Bloomington, Indiana, 2005-2007.
Professor, Department of Psychological and Brain Sciences, Programs in Neural Science, Clinical Science and Cognitive Science, Indiana University, Bloomington, Indiana, 2007-2009
Professor, School of Psychology, Psychiatry, and Psychological Medicine, Monash University, 2007-present
Director, Clinical Cognitive Neuroscience Laboratory, Monash University, 2007 - present
Consulting
Current or previous consultant to:
Eli Lilly and Co., Prana Biotechnology Ltd, GSK PLC, Roche, Teva Pharmaceuticals
Monash teaching commitment
PSY1011 Psychology 1A
PSY2031 Developmental and biological psychology
PSY2042 Cognitive and social psychology
PSY4270 Psychological assessment
DPSY5162 Neuroanatomy for the clinical neuropsychologist
DPSY5261 Neuropsychological models of cognition and behaviour part 1
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
External positions
Director, ZindaMetrix
1 Jul 2017 → …
Research area keywords
- Brain Imaging
- Cognitive Assessment
- Cognitive Assessment in Clinical Trials
- Cognitive Neuroscience
- Decision Making
- Drug Addiction
- Huntington's Disease
- Impulsivity
- Movement Disorders
- Neuropsychiatric Assessment
- Problem Gambling
Network
-
-
-
A Prospective Registry Study in a Global Huntington's Disease Cohort (Enroll-HD)
Stout, J. & Georgiou-Karistianis, N.
10/06/13 → 8/07/28
Project: Research
-
Assessing the impact of a coordinated outpatient interdisciplinary care delivery on outcomes and satisfaction in Huntington’s disease
Lie, Y., Mathers, S., Hosken, R., Phan, T. & Stout, J.
1/01/22 → 31/12/22
Project: Research
-
A single bout of moderate-intensity aerobic exercise improves motor learning in premanifest and early Huntington’s disease
Andrews, S. C., Kämpf, L., Curtin, D., Hinder, M., Wenderoth, N., Stout, J. C. & Coxon, J. P., 2023, In: Frontiers in Psychology. 14, 9 p., 1089333.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Clinical associations of cognitive dysfunction in systemic lupus erythematosus
Raghunath, S., Glikmann-Johnston, Y., Golder, V., Kandane-Rathnayake, R., Morand, E. F., Stout, J. C. & Hoi, A., 28 Feb 2023, In: Lupus Science and Medicine. 10, 1, 10 p., e000835.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Cognition-oriented treatments and physical exercise on cognitive function in Huntington’s disease: a systematic review
Huynh, K., Nategh, L., Jamadar, S., Stout, J., Georgiou-Karistianis, N. & Lampit, A., Apr 2023, In: Journal of Neurology. 270, 4, p. 1857-1879 23 p.Research output: Contribution to journal › Review Article › Research › peer-review
-
Effects of medial prefrontal transcranial alternating current stimulation on neural activity and connectivity in people with Huntington's disease and neurotypical controls
Davis, M. C., Fitzgerald, P. B., Bailey, N. W., Sullivan, C., Stout, J. C., Hill, A. T. & Hoy, K. E., 15 Jul 2023, In: Brain Research. 1811, 12 p., 148379.Research output: Contribution to journal › Article › Research › peer-review
-
Fibromyalgia, mood disorders, cognitive test results, cognitive symptoms and quality of life in systemic lupus erythematosus
Raghunath, S., Guymer, E., Glikmann-Johnston, Y., Golder, V., Kandane-Rathnayake, R. K., Morand, E. F., Stout, J. C. & Hoi, A., Jan 2023, In: Rheumatology. 62, 1, p. 190-199 10 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus)
Prizes
-
Fellow, Academy of Social Sciences in Australia (Panel D) 2018
Stout, Julie (Recipient), 2018
Prize: Election to learned society